AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain.
ACRX (Common Stock) $3.73-0.08 (1.84%)
|Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources|
Wednesday, August 2, 20174:30 p.m. ET
Q2 2017 AcelRx Pharmaceuticals, Inc. Earnings Conference Call
|Get help downloading or viewing the above file types|
Receive E-mail Alerts
|Sign up to receive e-mail alerts whenever AcelRx Pharmaceuticals, Inc. posts new information to the site. Just enter your e-mail address and click Submit.|